Wolverine Trading, LLC Lexicon Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.39 $10,721 - $16,969	-7,100 Reduced 37.37%	11,900 $18,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $29,260 - $43,319	19,000 New	19,000 $31,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $33,400 - $51,102	33,400 New	33,400 $51,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $7,960 - $10,720	4,000 Added 33.33%	16,000 $37,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $21,600 - $30,720	12,000 New	12,000 $23,000
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $524 - $1,076	400 Added 1.4%	28,900 $65,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $2,145 - $4,279	-1,100 Reduced 3.72%	28,500 $60,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $58,293 - $94,248	15,300 Added 106.99%	29,600 $123,000
Q3 2021 Nov 12, 2021	SELL	$3.38 - $5.35 $42,588 - $67,410	-12,600 Reduced 46.84%	14,300 $70,000
Q2 2021 Aug 06, 2021	SELL	$4.12 - $5.87 $60,564 - $86,289	-14,700 Reduced 35.34%	26,900 $135,000
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $30,360 - $79,992	8,800 Added 26.83%	41,600 $236,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $3.67 $17,010 - $59,454	16,200 Added 97.59%	32,800 $109,000
Q3 2020 Nov 13, 2020	BUY	$1.44 - $2.1 $4,608 - $6,720	3,200 Added 23.88%	16,600 $24,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $23,450 - $30,819	13,400 New	13,400 $27,000
Q1 2020 May 11, 2020	SELL	$1.8 - $4.28 $33,660 - $80,036	-18,700 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$3.16 - $5.15 $4,424 - $7,210	-1,400 Reduced 6.97%	18,700 $77,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $13,080 - $72,594	-10,900 Reduced 35.16%	20,100 $69,000
Q2 2019 Aug 20, 2019	BUY	$5.35 - $7.11 $29,959 - $39,816	5,600 Added 22.05%	31,000 $195,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $110,744 - $201,676	25,400 New	25,400 $141,000
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $113,520 - $143,660	-11,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $2,358 - $3,417	-300 Reduced 2.65%	11,000 $94,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $37,711 - $52,804	-4,300 Reduced 27.56%	11,300 $112,000
Q3 2017 Nov 15, 2017	BUY	$12.17 - $16.3 $189,852 - $254,280	15,600	15,600 $192,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $162M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account